Medication info
Astatin Tablet 10 mg (Atorvastatin Calcium Hydrate)

Astatin Tablet 10 mg (Atorvastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Celix Co., Ltd.
Appearance
White, round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200708455 · Approved 2007.07.23 · Insurance code 646201280

Summary

Main use
Improvement of hyperlipidemia, prevention of cardiovascular disease (such as myocardial infarction and stroke)
Who takes it
Adults · Children
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medication is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia: The dose of this medication is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or use it when such treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
Child dose
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses of this medication higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate for each patient according to the recommended treatment goal. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Celix Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia, prevention of cardiovascular disease (such as myocardial infarction and stroke)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication helps to reduce the risk of cardiovascular diseases. It particularly decreases the risks of myocardial infarction, stroke, the need for vascular surgery, and angina. It also lowers total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels in patients with hyperlipidemia while increasing HDL-cholesterol levels, effectively improving blood lipids. It is also used in pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia in conjunction with diet to lower cholesterol levels. Therefore, this medication is used for reducing the risk of cardiovascular diseases and treating hyperlipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medication is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia: The dose of this medication is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or use it when such treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.

Child dose

Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses of this medication higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate for each patient according to the recommended treatment goal. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle problems, so if there is severe muscle pain or weakness, or significantly elevated creatine kinase levels, discontinue taking it immediately. Special caution is needed if serious myopathy or rhabdomyolysis is suspected as it may affect kidney function. Patients with an allergic reaction to this medication, liver disease, muscle disease, those who are pregnant or breastfeeding, children, or patients on certain medications should not take this medication. Those with a history of alcohol abuse or liver disease, patients with reduced kidney function, and the elderly should use this medication with caution, regularly checking for muscle-related symptoms. This medication can affect liver function, so liver function tests and symptom monitoring are necessary, and if symptoms like nausea, vomiting, or fatigue occur, medical personnel should be notified. Appropriate contraception should be practiced during the use of this medication, and it should not be used during pregnancy. This medication can interact with several other medications, so if you are taking other medications, you must inform your healthcare provider, especially when combined with specific antibiotics, antifungals, or HIV treatments. There is no specific antidote for overdose, thus treatment based on symptoms and monitoring liver function and muscle enzyme levels is required. Keep out of reach of children and store safely in the original container.

Side effects

  • A sense of weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 174 more
  • anorexia
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngalgia
  • laryngalgia
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • altered perception
  • sensory loss
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive leukocytes in urine
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • peptic duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • post-prandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbance
  • vertigo
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional lability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesis
  • depression
  • hypertonia
  • myositis
  • muscle disease
  • arthritis
  • bursitis
  • synovitis
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • renal stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • lethargy
  • vasomotor edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • cervical rigidity
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • hypogeusia
  • ageusia
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • hyperlipidemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hypertrophy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1°C and 30°C room temperature. Proper storage will help maintain the effectiveness and safety of the medication for a longer period.

Appearance and packaging

Appearance

White, round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.